Metraipolis › archive › dc_6903e1fcbd06

RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m6A methylation of TNFSF9 and inducing polarization of tumor-associated… — Europe PMC PMID:40830812

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40830812
DOI
10.1186/s41065-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-10T12:56:58.461Z
SHA-256 of the archived text
7bf4422266390610087c281e73329eda98dd231c45d06c98b624d50c81041e66
Stable URL of this page
https://metraipolis.com/documento/dc_6903e1fcbd06

How to cite

RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m6A methylation of TNFSF9 and inducing polarization of tumor-associated… — Europe PMC PMID:40830812 — Europe PMC (en), https://europepmc.org/article/MED/40830812 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6903e1fcbd06 (Metraipolis archive dc_6903e1fcbd06, sha256 7bf4422266390610087c281e73329eda98dd231c45d06c98b624d50c81041e66)
BibTeX
@misc{dc6903e1fcbd06,
  title = {RBM15 enhances paclitaxel resistance in triple-negative breast cancer by targeting m6A methylation of TNFSF9 and inducing polarization of tumor-associated… — Europe PMC PMID:40830812},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40830812},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6903e1fcbd06; sha256 7bf4422266390610087c281e73329eda98dd231c45d06c98b624d50c81041e66},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40830812. Agents can read the archived copy with the MCP tool read_document.